Quo Vadis Trastuzumab?: Navigating Cardiac Safety Risk Estimates With Complex Cancer Treatments.

MedStar author(s):
Citation: JACC Heart Failure. 7(3):225-227, 2019 03.PMID: 30819378Institution: MedStar Heart & Vascular InstitutenaForm of publication: Journal ArticleMedline article type(s): Comment | EditorialSubject headings: *Breast Neoplasms | *Heart Failure | Cardiotoxicity | Chemotherapy, Adjuvant | Heart | Humans | TrastuzumabYear: 2019ISSN:
  • 2213-1779
Name of journal: JACC. Heart failureAll authors: Barac AFiscal year: FY2019Digital Object Identifier: Date added to catalog: 2020-02-10
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 30819378 Available 30819378

English

Powered by Koha